(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
End-of-Phase 2A Meetings (EoP2)
Confidentiality agreement (CDA)
efficacy
Quality Assurance
Deviation
Biologics License Application (BLA)
Active Pharmaceutical Ingredient (API)
Endpoint
Potency
Investigational New Drug Application (IND)
21 CFR Part 210
Specificity
Purity
Drug product
ex vivo
International Conference on Harmonization (ICH)
pharmacodynamics
Chemistry Manufacturing Controls (CMC)
Carcinogenicity
New Chemical Entity (NCE)
Functionality
Batch Records
Drug Master File (DMF)
FDA Expedited Programs or Fast-Track review
Center for Biologics Evaluation and Research (CBER)
Oncologic Drugs Advisory Committee (ODAC)
Pre-Clinical
ISO 8
Identity
505(b)(1) vs. 505(b)(2)
Quality Control
Orphan drug designation (ODD)
Bioequivalence
Teratogenicity
Allogeneic
CRISPR
Adverse event
Immunogenic
Non-disclosure agreement (NDA)
INitial Targeted Engagement for Regulatory Advice CBER producTs (INTERACT)
